Now Available in the ThreatQuotient Marketplace, the Integration Provides Security Teams with Timely Updates on Known Exploited Vulnerabilities, Attack Vectors and Threat Actor Activities LEXINGTON, ...
QUOTIENT SCIENCES COMPLETES INTEGRATION OF DRUG SUBSTANCE INTO TRANSLATIONAL PHARMACEUTICS® PLATFORM
Quotient Sciences – a global drug development and manufacturing accelerator offering a suite of services to clients in the pharmaceutical and biotech industry – announces that it has integrated drug ...
ThreatQuotient™, a security operations platform innovator, announces that the ThreatQ™ integration with MITRE ATT&CK™ now includes support for PRE-ATT&CK and Mobile. Together with Enterprise ATT&CK, ...
Quotient Sciences announces that it has integrated drug substance into its flagship Translational Pharmaceutics platform. Quotient Sciences announced on Feb. 17, 2022 that it has integrated drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results